Peptide pulsed dendritic cell

BIOLOGICAL2 trials

Sponsors

Kanazawa University, Universidad Nacional de Colombia

Conditions

Breast Cancer FemaleHepatocellular carcinoma

Phase 1

Personalized Vaccine for Cancer Immunotherapy

CompletedNCT04879888

Universidad Nacional de ColombiaBreast Cancer Female

Start: 2016-08-31End: 2017-07-30Updated: 2021-05-10

Unknown Phase

Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinoma

Active, not recruitingJPRN-UMIN000020811

Kanazawa UniversityHepatocellular carcinoma

Start: 2016-02-01Target: 10Updated: 2026-06-29